Stool Calprotectin at Dr. Essa Lab

Stool Calprotectin at Dr. Essa Lab

The Stool Calprotectin test at Dr. Essa Lab is a highly specialized, non-invasive diagnostic laboratory investigation used to detect and quantify gastrointestinal inflammation. Calprotectin is a calcium- and zinc-binding protein complex found abundantly in the cytosol of neutrophilic granulocytes, representing up to sixty percent of their total soluble protein content. When inflammatory processes occur within the gastrointestinal tract, neutrophils rapidly migrate through the mucosal wall into the intestinal lumen. As these cells undergo activation, degranulation, or apoptosis, they release calprotectin directly into the fecal stream. Because calprotectin is remarkably resistant to enzymatic degradation by intestinal bacteria and remains stable in stool specimens for several days at room temperature, it serves as an exceptionally reliable, stable, and sensitive fecal biomarker for localized gut inflammation.

The primary clinical utility of this test lies in its ability to differentiate between organic inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis, and functional gastrointestinal disorders, most notably irritable bowel syndrome. Patients with irritable bowel syndrome often present with symptoms that closely mimic inflammatory bowel disease, including chronic abdominal pain, bloating, and altered bowel habits. However, because irritable bowel syndrome is non-inflammatory, stool calprotectin levels remain within the normal reference range. Conversely, patients with active inflammatory bowel disease exhibit significantly elevated levels. This distinction is vital because it prevents patients with irritable bowel syndrome from undergoing unnecessary, invasive, and expensive diagnostic procedures like colonoscopy and ileoscopy, while ensuring that patients with suspected inflammatory bowel disease are promptly referred for endoscopic evaluation and targeted therapeutic intervention.

In addition to its diagnostic value, the Stool Calprotectin test is an invaluable tool for monitoring disease activity, predicting clinical relapse, and assessing treatment response in patients with established inflammatory bowel disease. By measuring calprotectin levels serially, gastroenterologists can objectively evaluate the efficacy of anti-inflammatory or biologic therapies and detect subclinical inflammation before symptoms manifest clinically. Dr. Essa Lab, a premier diagnostic institution in Karachi, Pakistan, utilizes advanced automated enzyme-linked immunosorbent assay platforms to perform this analysis, ensuring that patients and clinicians receive highly accurate, reproducible, and timely quantitative results to guide critical clinical decisions.

Clinical Procedure: What to Expect

Patient Preparation

• Medication Review: Patients should inform their prescribing physician of all medications they are currently taking. Non-steroidal anti-inflammatory drugs, such as ibuprofen, naproxen, diclofenac, and high-dose aspirin, can cause minor mucosal inflammation in the gastrointestinal tract, leading to falsely elevated calprotectin levels. Under medical supervision, these medications should ideally be discontinued for two to seven days prior to sample collection.
• Proton Pump Inhibitors: The use of proton pump inhibitors has been associated with mildly elevated calprotectin levels due to alterations in gastric acid barriers and gut microbiota. Patients should discuss the temporary suspension of these medications with their doctor.
• Dietary and Fasting Guidelines: There are no specific dietary restrictions or fasting requirements for this test. Patients may continue their normal eating and drinking habits prior to sample collection.
• Avoid External Contamination: Do not collect the stool sample during active menstruation or when suffering from actively bleeding hemorrhoids, as the introduction of blood from these sources can artificially elevate calprotectin levels.
• Sample Integrity: Ensure that the stool specimen is not contaminated with urine, toilet water, or household cleaning chemicals, as these can dilute the sample or interfere with the laboratory reagents.

During the Procedure

The specimen collection process is straightforward and is performed by the patient in the comfort of their home. Dr. Essa Lab provides a sterile, leak-proof specimen container equipped with an integrated collection spoon attached to the cap. To collect the sample, the patient should defecate into a clean, dry receptacle or onto a clean sheet of paper placed over the toilet seat. Using the collection spoon, a small portion of the stool—approximately the size of a walnut or a spoonful of liquid stool—should be transferred into the sterile container. It is important to collect material from different areas of the stool sample, especially any areas that appear unusual or loose.

Once the sample is secured, the container cap must be screwed on tightly to prevent leakage. The container must be clearly labeled with the patient’s full name, date of birth, and the exact date and time of collection. For optimal clinical accuracy, the specimen should be transported to the nearest Dr. Essa Lab collection center immediately, preferably within two hours of collection. If a delay is unavoidable, the sample may be stored in a domestic refrigerator at two to eight degrees Celsius for up to twenty-four hours, but it must never be frozen or exposed to direct heat or sunlight. Upon arrival at the laboratory, experienced technicians process the sample using state-of-the-art enzyme-linked immunosorbent assay technology to measure the precise concentration of calprotectin in micrograms per gram of stool.

When is a Stool Calprotectin Performed?

Differentiation Between Inflammatory Bowel Disease and Irritable Bowel Syndrome

Physicians frequently request a Stool Calprotectin test when a patient presents with overlapping gastrointestinal symptoms such as chronic abdominal pain, bloating, and altered bowel habits. Because the clinical presentations of inflammatory bowel disease and irritable bowel syndrome are highly similar, clinical symptoms alone are often insufficient for an accurate diagnosis. Stool calprotectin serves as a highly specific biomarker for mucosal inflammation, allowing clinicians to confidently rule out active inflammatory bowel disease if the levels are normal, thereby avoiding invasive endoscopic procedures for patients with functional disorders.

Monitoring Disease Activity and Predicting Relapse in Diagnosed IBD Patients

For patients already diagnosed with Crohn’s disease or ulcerative colitis, the Stool Calprotectin test is performed periodically to monitor the inflammatory status of the gut mucosa. Clinical symptoms do not always correlate perfectly with the degree of mucosal inflammation. A rising trend in calprotectin levels often precedes a clinical flare-up by several weeks or months. This early warning allows gastroenterologists to proactively adjust maintenance therapy, optimize medication dosages, and prevent full-blown clinical relapses before severe symptoms develop.

Evaluation of Chronic Diarrhea and Persistent Abdominal Pain

Chronic diarrhea, defined as loose stools lasting for more than four weeks, presents a diagnostic challenge with numerous potential etiologies. Clinicians utilize the Stool Calprotectin test as an initial screening tool to classify the diarrhea as inflammatory or non-inflammatory. Elevated levels point toward inflammatory causes such as microscopic colitis, infectious colitis, or inflammatory bowel disease, whereas normal levels suggest malabsorptive, secretory, or functional causes, helping to streamline the subsequent diagnostic pathway.

Assessing Mucosal Healing and Treatment Response

The primary therapeutic goal in modern inflammatory bowel disease management has shifted from merely controlling symptoms to achieving complete mucosal healing. Serial measurements of stool calprotectin provide a non-invasive, objective method to assess whether the intestinal mucosa is healing in response to medical therapies, such as biologic agents, immunomodulators, or corticosteroids. A significant decline in calprotectin levels toward the normal range indicates successful therapeutic response and mucosal recovery.

Screening Tool to Avoid Unnecessary Invasive Endoscopy

Colonoscopy with biopsy is the gold standard for diagnosing structural bowel diseases, but it is invasive, expensive, carries minor risks, and can cause significant patient anxiety. The Stool Calprotectin test is performed as an effective gatekeeper or screening tool. Due to its exceptionally high negative predictive value, a normal calprotectin result strongly suggests the absence of significant mucosal inflammation, allowing physicians to safely defer invasive endoscopic evaluations in low-risk patients.

What Does a Stool Calprotectin Detect?

The Stool Calprotectin test is highly sensitive to the presence of neutrophils in the gastrointestinal lumen, allowing it to detect a wide spectrum of organic inflammatory and structural pathologies. Specifically, this test can detect active mucosal inflammation associated with Crohn’s disease flare-ups, active ulcerative colitis, and infectious gastroenteritis caused by bacterial pathogens such as Salmonella, Shigella, Campylobacter, or Clostridioides difficile. It also identifies mucosal damage resulting from non-steroidal anti-inflammatory drug enteropathy, active diverticulitis, microscopic colitis, and eosinophilic gastroenteritis. Furthermore, elevated calprotectin levels can be detected in cases of colorectal neoplasia, large adenomatous polyps, food protein-induced enterocolitis, gastrointestinal graft-versus-host disease, ischemic colitis, radiation-induced proctitis, and celiac disease with active mucosal damage. Conversely, the test detects a normal, non-inflammatory state of the intestinal mucosa, which is characteristic of functional gastrointestinal disorders such as irritable bowel syndrome, fibromyalgia-associated functional bowel symptoms, and successful mucosal healing following appropriate therapeutic intervention.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is committed to providing rapid, reliable, and highly accurate diagnostic services. The turnaround time for the Stool Calprotectin test is typically twenty-four to forty-eight hours from the time the specimen is received at the laboratory. Once the analysis is completed and verified by our consultant pathologists, patients receive an automated SMS notification containing a secure link to access their digital report. Reports can also be viewed and downloaded directly from the official Dr. Essa Lab online portal by entering the unique lab ID and password provided on the receipt. For patients who prefer physical copies, printed reports can be collected from the respective diagnostic center branch where the sample was submitted or from any convenient Dr. Essa Lab collection point across Karachi and other major cities.

Stool Calprotectin Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Calprotectin Concentration (Adults)	Less than 50 micrograms per gram (µg/g)	50 to 120 µg/g (Borderline/mild inflammation); Greater than 120 µg/g (Significant active inflammation)
Calprotectin Concentration (Children 1-4 years)	Less than 150 micrograms per gram (µg/g)	Greater than 150 µg/g (Indicates potential pediatric gastrointestinal pathology)
Clinical Correlation: IBD vs IBS	Normal levels point strongly toward Irritable Bowel Syndrome or functional disorders	Elevated levels point toward active Inflammatory Bowel Disease, infection, or mucosal damage
Therapeutic Response Monitoring	Consistently low or decreasing levels indicating mucosal healing	Persistently high or rising levels indicating active disease or impending clinical relapse
Infectious Colitis Assessment	Normal levels once the gastrointestinal infection has fully resolved	Elevated levels during acute bacterial, viral, or parasitic gastroenteritis
Drug-Induced Mucosal Injury	Normal levels in the absence of mucosal irritation from medications	Elevated levels due to non-steroidal anti-inflammatory drug-induced enteropathy
Neoplastic/Polyp Related Inflammation	Normal levels as most benign polyps do not cause significant neutrophil migration	Mildly to moderately elevated levels in large adenomas or colorectal malignancies

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Stool Calprotectin?

• Experienced healthcare professionals: Our laboratory is staffed by highly qualified consultant pathologists and clinical scientists who oversee all testing procedures.
• Patient-focused care: We prioritize patient comfort and convenience, providing clear instructions and support throughout the sample collection process.
• Quality diagnostic services: Dr. Essa Lab adheres to strict international quality control standards, ensuring the highest level of accuracy and reproducibility.
• Professional reporting: We deliver comprehensive, easy-to-understand quantitative reports that facilitate precise clinical decision-making for gastroenterologists.
• Modern diagnostic approach: Our laboratories are equipped with state-of-the-art automated ELISA platforms for precise biomarker quantification.
• Comfortable environment: All our collection centers are designed to provide a clean, hygienic, and welcoming environment for patients.
• Convenient location: With an extensive network of branches across Karachi and other cities, finding a nearby collection center is effortless.
• Commitment to accurate diagnosis: We are dedicated to providing timely and precise diagnostic insights that contribute directly to improved patient outcomes.